Results 31 to 40 of about 12,185 (167)

Pyoderma Gangrenosum: A Retrospective Study of Clinical Charac­teristics, Comorbidities, Response to Treatment and Mortality Related to Prednisone Dose

open access: yesActa Dermato-Venereologica, 2021
Pyoderma gangrenosum is an uncommon ulcerative neutrophilic dermatosis. Clinical presentation, location and associated diseases are diverse. Treatment of pyoderma gangrenosum includes treating the underlying comorbidity supplemented with topical and/or ...
Louise Schøsler   +2 more
doaj   +1 more source

Pyoderma gangrenosum of the eyelid associated with inflammatory bowel disease

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: Pyoderma gangrenosum (PG) of the eyelid can be difficult to diagnosis and may mimic other, more common pathologies, thereby delaying proper treatment and management.
Larissa A. Habib   +5 more
doaj   +1 more source

An Unusual Association of Pyoderma Gangrenosum with Henoch-Schonlein Purpura in a Child [PDF]

open access: yes, 2017
Henoch-Schonlein purpura (HSP) is a systemic vasculitis affecting small vessels. Pyoderma gangrenosum (PG) is an uncommon, non-infectious, neutrophilic dermatosis.
Kasapcopur, Ozgur   +9 more
core   +1 more source

Line‐Field Confocal Optical Coherence Tomography: A Diagnostic Tool Facilitating the Diagnosis of Sweet's Syndrome. A Case Report

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Sweet's syndrome is a rare neutrophilic dermatosis characterized by an acute onset of erythematous and infiltrative lesions. Diagnosis is based on clinical, histopathological, and laboratory findings. We propose that non‐invasive skin imaging techniques, such as line‐field confocal optical coherence tomography (LC‐OCT), may be beneficial for ...
Aleksandra Anderson   +5 more
wiley   +1 more source

Pioderma gangrenoso bolhoso e síndrome mielodisplásica Bullous pyoderma gangrenosum and myelodysplastic syndrome

open access: yesAnais Brasileiros de Dermatologia, 2006
O pioderma gangrenoso pode apresentar-se como manifestação paraneoplásica. Relata-se um caso de pioderma gangrenoso, da variante bolhosa, acompanhado de bicitopenia, em que foi evidenciado, por meio de mielograma, biópsia de medula óssea e cariótipo ...
Mariana Dias Batista   +7 more
doaj   +1 more source

Pyoderma gangrenosum in refractory celiac disease: a case report [PDF]

open access: yes, 2013
Pyoderma gangrenosum is an inflammatory neutrophilic dermatosis characterized by painful cutaneous ulcerations and often associated with systemic inflammatory and neoplastic diseases.
PALLONE, FRANCESCO   +17 more
core   +2 more sources

Subcorneal Pustular Dermatosis, a Systematic Review and Pooled Analysis of a Rare and Underdiagnosed Disease

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Subcorneal pustular dermatosis (SPD), or Sneddon–Wilkinson disease, is a rare, relapsing pustular skin condition of unknown cause, characterised by subcorneal pustules. Objectives To summarise the demographic, clinical, histopathological, management and disease course of SPD.
Mason H. Crossman   +5 more
wiley   +1 more source

An unusual presentation of celiac disease in adult patient

open access: yesClinical Case Reports, 2022
Pyoderma gangrenosum is among the exceptional extra‐intestinal manifestations of celiac disease. We report a case of a 52‐year‐old patient who presented with pyoderma gangrenosum that turned out to be the initial presentation of celiac disease.
Refka Frioui   +5 more
doaj   +1 more source

Vegetative pyoderma gangrenosum [PDF]

open access: yes, 2015
Vegetative pyoderma gangrenosum is a rare, superficial variant of pyoderma gangrenosum that is more commonly found on the trunk as single or multiple, non-painful lesions. There is typically no associated underlying systemic disease.
Hale, Christopher S   +12 more
core   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy